Omeros Corporation (OMER): Novo Nordisk Deal Creating Buzz
Latest reports show that Omeros Corporation (NASDAQ:OMER) has closed a deal worth around $2.1 billion with drug giant Novo Nordisk for the zaltenibart, a phase 2 asset of the former, in development for...




